$ACUR: Acura Pharma exploring a full range of fina
Post# of 22756
4:15 PM ET 1/3/17 | Briefing.com
Alternatives to a sale of the company include a capital raising transaction, a licensing transaction and a sale of certain assets. There can be no assurance a transaction will result from this process and the co does not intend to disclose additional details unless and until it has entered into a specific transaction